| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.382 | 142.375 | 47.448 | 62.904 | 11.562 | 0 | 74.243 | 82.942 | 80.662 | 150.348 |
| Total Income - EUR | 64.387 | 142.713 | 47.518 | 62.949 | 11.917 | 2.533 | 74.606 | 82.858 | 80.759 | 157.624 |
| Total Expenses - EUR | 42.326 | 67.409 | 38.837 | 12.639 | 8.301 | 2.073 | 15.093 | 22.598 | 25.144 | 34.876 |
| Gross Profit/Loss - EUR | 22.061 | 75.304 | 8.681 | 50.310 | 3.616 | 460 | 59.513 | 60.260 | 55.614 | 122.748 |
| Net Profit/Loss - EUR | 20.130 | 70.177 | 7.563 | 48.423 | 3.259 | 384 | 58.020 | 59.448 | 54.871 | 119.100 |
| Employees | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Rost Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.353 | 24.489 | 23.066 | 26.072 | 24.104 | 23.352 | 20.329 | 19.489 | 18.383 | 17.345 |
| Current Assets | 18.547 | 55.951 | 9.996 | 23.492 | 3.123 | 3.299 | 41.374 | 46.930 | 50.197 | 106.664 |
| Inventories | 0 | 0 | 45 | 44 | 107 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.271 | 10.838 | 7.695 | 23.486 | 3.024 | 2.679 | 40.090 | 46.472 | 50.230 | 87.585 |
| Cash | 12.276 | 45.113 | 2.256 | -38 | -8 | 619 | 1.284 | 458 | -34 | 19.079 |
| Shareholders Funds | 39.005 | 70.230 | 31.855 | 48.535 | 25.566 | 25.465 | 58.710 | 59.497 | 55.121 | 119.148 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.128 | 10.449 | 1.252 | 1.085 | 1.672 | 1.195 | 2.993 | 6.941 | 13.463 | 4.861 |
| Income in Advance | 9 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Rost Clinical Research Srl